logo
  • Home
  • About Us
    • About Us
    • Why Raglan
    • Careers
  • Selected Transactions
  • Raglan IPO Projects
    • Raglan Pharmaceutical & Life Science Projects
    • Raglan Natural Resources
  • News
  • Contact us
  • Search
Open Orphan starts trials on nasal spray COVID-19 vaccines
  1. Home
  2. 2021
  3. Open Orphan starts trials on nasal spray COVID-19 vaccines

Recent News

  • Open Orphan subsidiary develops human study for malaria
  • Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbocharge work
  • The Executive Chairman of Open Orphan plc (LON:ORPH), Cathal Friel, Just Bought 2.5% More Shares
  • BRIEF—COVID-19 human challenge study to expand
  • Open Orphan launches infectious disease spinout
  • Our flu drug is not to be sniffed at, says Poolbeg Pharma chief Jeremy Skillington
  • Prev
  • Next
Join us for our newsletters
Loading

Raglan Capital
4th Floor,
Fitzwilliam Hall,
Fitzwilliam Place,
Dublin 2
D02 T292
T: +353 1 6440007
E: info@raglancapital.ie

  • Contact us
  • Careers
  • Privacy Policy
  • Cookie policy (EU)
Join us for our newsletters
Loading

Raglan Capital
4th Floor,
Fitzwilliam Hall,
Fitzwilliam Place,
Dublin 2
D02 T292
T: +353 1 6440007
E: info@raglancapital.ie

  • Contact us
  • Careers
  • Privacy Policy
  • Cookie policy (EU)
© 2021 Raglan Capital. All rights reserved

Privacy Preference Center

Privacy Preferences